A Study of PN20 in Healthy Adult Volunteers

NCT06523088 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Thrombocytopenia
Immune Thrombocytopenic Purpura

Interventions

DRUG: PN20
DRUG: Placebo

Sponsor

Chongqing Peg-Bio Biopharm Co., Ltd.